Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Study on Impact of Edoxaban Treatment in Italian Cancer Patients With Venous Thromboembolism (EDOI Cancer Study) During Antineoplastic Therapy

NCT04072068 is registered in ClinicalTrials.gov with Gruppo Oncologico Italiano di Ricerca Clinica as lead sponsor.

NCT NCT04072068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04072068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Study on Impact of Edoxaban Treatment in Italian Cancer Patients With Venous Thromboembolism (EDOI Cancer Study) During Antineoplastic Therapy
Lead sponsor
Gruppo Oncologico Italiano di Ricerca Clinica
Phase
Phase 4
Overall status
Completed
Start date
June 27, 2019
Completion date
March 8, 2022
Enrollment
150 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, thromboembolism